Viewing Study NCT05645718


Ignite Creation Date: 2025-12-25 @ 4:33 AM
Ignite Modification Date: 2026-03-04 @ 12:16 AM
Study NCT ID: NCT05645718
Status: RECRUITING
Last Update Posted: 2025-10-07
First Post: 2022-11-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module